GALM

galactose mutarotase

Basic information

Region (hg38): 2:38666081-38741237

Links

ENSG00000143891NCBI:130589OMIM:137030HGNC:24063Uniprot:Q96C23AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • galactosemia 4 (Moderate), mode of inheritance: AR
  • galactosemia 4 (Strong), mode of inheritance: AR
  • galactosemia 4 (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Galactosemia IVARBiochemicalDietary management (with a galactose-free diet) has been reported as resulting in normal galactose levels; some have been reported as resuming a normal diet in childhood and maintaining normal galactose levelsBiochemical; Ophthalmologic30451973; 30910422

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the GALM gene.

  • not provided (3 variants)
  • Galactosemia 4 (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the GALM gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
10
clinvar
3
clinvar
13
missense
29
clinvar
3
clinvar
2
clinvar
34
nonsense
3
clinvar
3
start loss
0
frameshift
1
clinvar
1
inframe indel
2
clinvar
2
splice donor/acceptor (+/-2bp)
0
splice region
1
2
3
non coding
16
clinvar
16
Total 3 0 32 13 21

Highest pathogenic variant AF is 0.0000526

Variants in GALM

This is a list of pathogenic ClinVar variants found in the GALM region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
2-38666166-C-T Inborn genetic diseases Likely benign (Jan 31, 2024)3098041
2-38666169-C-T Inborn genetic diseases Uncertain significance (Nov 17, 2022)2326882
2-38666174-A-G Inborn genetic diseases Uncertain significance (Dec 13, 2021)2401046
2-38666174-A-T Uncertain significance (Oct 17, 2022)1955913
2-38666183-G-A Uncertain significance (Aug 14, 2021)1450604
2-38666190-G-C Uncertain significance (Oct 13, 2022)1448953
2-38666196-T-C Uncertain significance (Oct 05, 2022)1423840
2-38666197-G-A Likely benign (Nov 21, 2023)2815653
2-38666223-A-G GALM-related disorder Uncertain significance (May 26, 2024)3346164
2-38666238-C-T Inborn genetic diseases Uncertain significance (Apr 08, 2024)3280513
2-38666255-G-T Inborn genetic diseases Uncertain significance (Feb 01, 2023)2480366
2-38666258-A-G Inborn genetic diseases Uncertain significance (Dec 03, 2024)3518412
2-38666274-G-A Inborn genetic diseases Uncertain significance (Oct 04, 2022)2316523
2-38666283-C-T Uncertain significance (Nov 24, 2022)2793268
2-38666308-G-A GALM-related disorder Benign (Jan 26, 2024)1259664
2-38666311-G-A Likely benign (Dec 30, 2023)2722446
2-38666325-T-C Inborn genetic diseases Uncertain significance (Oct 27, 2021)2257577
2-38666335-C-A Likely benign (Dec 13, 2023)2971859
2-38666518-A-G Benign (May 12, 2021)1274627
2-38666535-G-A Benign (May 12, 2021)1290378
2-38675784-T-C Benign (May 12, 2021)1179258
2-38675812-G-T Benign (May 25, 2021)1295014
2-38675880-T-A Benign (May 13, 2021)1268639
2-38675909-C-G Uncertain significance (Apr 10, 2023)2096442
2-38675916-C-A Pathogenic (Feb 27, 2022)2414354

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
GALMprotein_codingprotein_codingENST00000272252 775328
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
4.88e-110.058112557801701257480.000676
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.1461941881.030.000009792201
Missense in Polyphen7482.8660.89301947
Synonymous-0.8268979.61.120.00000442694
Loss of Function0.05121616.20.9867.73e-7192

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0008520.000852
Ashkenazi Jewish0.00009930.0000992
East Asian0.0009240.000925
Finnish0.002860.00282
European (Non-Finnish)0.0005350.000528
Middle Eastern0.0009240.000925
South Asian0.00006530.0000653
Other0.0004940.000489

dbNSFP

Source: dbNSFP

Function
FUNCTION: Mutarotase converts alpha-aldose to the beta-anomer. It is active on D-glucose, L-arabinose, D-xylose, D-galactose, maltose and lactose (By similarity). {ECO:0000250, ECO:0000269|PubMed:12753898, ECO:0000269|PubMed:15026423}.;
Pathway
Glycolysis / Gluconeogenesis - Homo sapiens (human);Galactose metabolism - Homo sapiens (human);Glycolysis;Glycogenosis, Type VII. Tarui disease;Gluconeogenesis;Glycogenosis, Type IA. Von gierke disease;Glycogenosis, Type IC;Fanconi-bickel syndrome;Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease;Triosephosphate isomerase;Fructose-1,6-diphosphatase deficiency;Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1);Glycogenosis, Type IB;NOTCH-Ncore;D-galactose degradation V (Leloir pathway);trehalose degradation;sucrose degradation (Consensus)

Recessive Scores

pRec
0.189

Intolerance Scores

loftool
0.826
rvis_EVS
-0.07
rvis_percentile_EVS
48.54

Haploinsufficiency Scores

pHI
0.147
hipred
N
hipred_score
0.350
ghis
0.429

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.976

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Galm
Phenotype

Gene ontology

Biological process
glucose metabolic process;galactose metabolic process;galactose catabolic process via UDP-galactose
Cellular component
cytoplasm;extracellular exosome
Molecular function
aldose 1-epimerase activity;carbohydrate binding